How does traditional gene therapy compare to the crispr-cas9 genome editing system?

Medicine

1 answer:

Yuri [45]1 year ago

7 0

Answer:

Traditional gene therapy requires a viral or non viral vector that normally takes longer to inject DNA with CrISPR-Cas9 they have one Cas9 that can take in a sequence and cut DNA anywhere and add the new gene in right there, and it has no risk of causing an immune response because of Virus DNA, and is more effective than using a plasmid or free flow DNA.

You might be interested in

Discuss the importance of accuracy and proper chart documentation in the event our doctor's claim is denied or payment is reduce

solong [7]

Answer:

Accurate documentation of medical records provides for program integrity, ensures patient safety and protects the provider.

Explanation:

7 0

1 year ago

Frank is overweight and seems unable to stick to any diet. Although his diet efforts suggest that he wants to lose weight, he de

mamaluj [8]

Answer:

cognitive dissonance

Explanation:

his actions are not matching his emotions, so he is trying to make them match each other

5 0

1 year ago

Sas<br>ppppppppppppppp<br>ooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

motikmotik

Answer:

what???

Explanation:

7 0

2 years ago

Lead time bias is best described as:A)an actually longer survival time for persons identified during a screening program because

dem82 [27]

The correct answer is D) An apparently longer survival time among persons identified during a screening program because they were identified at an earlier stage of their disease

Explanation:

In medicine, screening is a method to diagnose diseases even if the person has no symptoms; due to this, screening is related to earlier detection of diseases than traditional diagnosis based on symptoms. Early diagnosis does not imply longer survival time, but it can lead to doctors or individuals to perceive the survival time was longer, this phenomenon is known as lead-time bias.

For example, a person diagnosed with cancer at an early stage when he is 45 years old, dies at 50 years old, this means his survival time was 5 years. If the same person is diagnosed at 48 years based on symptoms and he dies at 50 it seems the survival time is less (2 years); however, this is biased as the diagnosis did not change the effect of the disease. According to this, lead-time bias can be described as "an apparently longer survival time among persons identified during a screening program because they were identified at an earlier stage of their disease".

4 0

2 years ago

I have an anatomy project and I was wondering how I make a valve that will empty into the "lungs" and not go back through?

Hitman42 [59]

Answer:

I Dont Know

Explanation:

I wish I could help you but I need some points so could you help a brother out?

5 0

2 years ago